tiprankstipranks
Aarey Drugs & Pharmaceuticals Ltd. (IN:AAREYDRUGS)
:AAREYDRUGS
India Market
AAREYDRUGS
Aarey Drugs & Pharmaceuticals Ltd.
RESEARCH TOOLSreports

Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) Ratios

0 Followers

Aarey Drugs & Pharmaceuticals Ltd. Ratios

IN:AAREYDRUGS's free cash flow for Q2 2026 was ₹0.03. For the 2026 fiscal year, IN:AAREYDRUGS's free cash flow was decreased by ₹ and operating cash flow was ₹0.03. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
 1.79 2.20 1.70 1.61 1.73
Quick Ratio
 1.52 1.73 1.26 1.22 1.28
Cash Ratio
 0.05 0.02 <0.01 <0.01 <0.01
Solvency Ratio
 0.03 0.06 0.04 0.03 0.06
Operating Cash Flow Ratio
 0.10 <0.01 -0.02 >-0.01 -0.04
Short-Term Operating Cash Flow Coverage
 0.29 0.03 -0.11 -0.04 -0.42
Net Current Asset Value
₹ 1.11B₹ 1.13B₹ 1.12B₹ 966.95M₹ 872.85M
Leverage Ratios
Debt-to-Assets Ratio
 0.17 0.15 0.10 0.13 0.06
Debt-to-Equity Ratio
 0.34 0.25 0.24 0.32 0.12
Debt-to-Capital Ratio
 0.25 0.20 0.19 0.24 0.11
Long-Term Debt-to-Capital Ratio
 <0.01 0.01 0.02 0.04 0.03
Financial Leverage Ratio
 1.98 1.72 2.28 2.48 2.16
Debt Service Coverage Ratio
 0.10 0.27 0.33 0.23 0.82
Interest Coverage Ratio
 -0.46 0.08 0.65 4.72 5.78
Debt to Market Cap
 0.25 0.34 0.27 0.62 0.14
Interest Debt Per Share
 19.85 13.86 14.06 15.99 6.73
Net Debt to EBITDA
 5.54 2.77 2.61 3.54 0.99
Profitability Margins
Gross Profit Margin
1.51%1.93%3.34%2.75%3.98%
EBIT Margin
1.86%2.14%2.46%2.12%2.46%
EBITDA Margin
2.01%2.55%2.89%2.49%2.86%
Operating Profit Margin
-0.67%0.06%0.71%3.23%2.40%
Pretax Profit Margin
1.47%1.29%1.35%1.44%2.04%
Net Profit Margin
0.88%0.85%1.19%0.90%1.33%
Continuous Operations Profit Margin
0.88%0.85%1.19%0.90%1.33%
Net Income Per EBT
59.64%65.95%87.66%62.69%65.37%
EBT Per EBIT
-221.07%1990.83%189.16%44.45%85.16%
Return on Assets (ROA)
1.17%1.69%1.54%1.29%2.67%
Return on Equity (ROE)
2.45%2.91%3.53%3.21%5.77%
Return on Capital Employed (ROCE)
-1.72%0.22%2.07%10.99%9.94%
Return on Invested Capital (ROIC)
-0.77%0.12%1.50%5.43%6.31%
Return on Tangible Assets
1.17%1.69%1.54%1.29%2.67%
Earnings Yield
1.69%3.89%4.02%6.19%6.57%
Efficiency Ratios
Receivables Turnover
 3.20 2.97 2.14 2.10 3.61
Payables Turnover
 4.65 8.58 2.96 3.17 4.30
Inventory Turnover
 9.84 10.22 5.30 6.20 8.41
Fixed Asset Turnover
 15.58 29.22 30.48 30.06 33.98
Asset Turnover
 1.33 1.99 1.30 1.44 2.01
Working Capital Turnover Ratio
 6.89 4.08 3.62 4.31 5.47
Cash Conversion Cycle
 72.77 116.07 115.99 117.81 59.78
Days of Sales Outstanding
 114.23 122.87 170.42 173.99 101.18
Days of Inventory Outstanding
 37.09 35.71 68.81 58.91 43.39
Days of Payables Outstanding
 78.55 42.52 123.24 115.08 84.79
Operating Cycle
 151.32 158.59 239.23 232.90 144.57
Cash Flow Ratios
Operating Cash Flow Per Share
 5.13 0.32 -1.18 -0.50 -1.87
Free Cash Flow Per Share
 1.60 -1.54 -1.46 -0.92 -2.78
CapEx Per Share
 3.53 1.86 0.28 0.41 0.91
Free Cash Flow to Operating Cash Flow
 0.31 -4.82 1.24 1.81 1.49
Dividend Paid and CapEx Coverage Ratio
 1.45 0.17 -4.14 -1.23 -2.04
Capital Expenditure Coverage Ratio
 1.45 0.17 -4.14 -1.23 -2.04
Operating Cash Flow Coverage Ratio
 0.29 0.03 -0.10 -0.03 -0.32
Operating Cash Flow to Sales Ratio
 0.04 <0.01 >-0.01 >-0.01 >-0.01
Free Cash Flow Yield
2.25%-4.17%-3.19%-3.82%-6.71%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 59.20 25.70 24.85 16.16 15.22
Price-to-Sales (P/S) Ratio
 0.52 0.22 0.29 0.15 0.20
Price-to-Book (P/B) Ratio
 1.37 0.75 0.88 0.52 0.88
Price-to-Free Cash Flow (P/FCF) Ratio
 44.54 -23.99 -31.32 -26.20 -14.91
Price-to-Operating Cash Flow Ratio
 13.93 115.57 -38.88 -47.56 -22.21
Price-to-Earnings Growth (PEG) Ratio
 -12.53 -1.15 1.06 -0.36 -6.07
Price-to-Fair Value
 1.37 0.75 0.88 0.52 0.88
Enterprise Value Multiple
 31.32 11.34 12.80 9.37 8.09
Enterprise Value
 2.46B 1.37B 1.46B 979.36M 1.14B
EV to EBITDA
 31.32 11.34 12.80 9.37 8.09
EV to Sales
 0.63 0.29 0.37 0.23 0.23
EV to Free Cash Flow
 54.12 -31.74 -39.33 -42.12 -16.99
EV to Operating Cash Flow
 16.87 152.87 -48.82 -76.45 -25.32
Tangible Book Value Per Share
 52.31 49.36 52.24 46.25 47.20
Shareholders’ Equity Per Share
 52.31 49.36 52.24 46.25 47.20
Tax and Other Ratios
Effective Tax Rate
 0.40 0.34 0.12 0.37 0.35
Revenue Per Share
 137.38 168.94 155.47 165.04 204.20
Net Income Per Share
 1.21 1.43 1.84 1.49 2.72
Tax Burden
 0.60 0.66 0.88 0.63 0.65
Interest Burden
 0.79 0.60 0.55 0.68 0.83
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 2.95 0.22 -0.64 -0.21 -0.45
Currency in INR